Donaldson Company, Inc. (DCI) kicked off its fiscal 2026 with momentum, reporting first-quarter results that exceeded analyst expectations and prompted the filtration systems manufacturer to raise its full-year outlook. Shares jumped over 2.5% in premarket trading Thursday following the announcement.
The company posted sales of $935.4 million for the quarter, beating the consensus estimate of $922.9 million. That 3.9% year-over-year increase came courtesy of volume growth, favorable currency translation, and pricing power—a combination that's increasingly valuable in today's uncertain economic environment.
The bottom line looked even better. GAAP net earnings climbed to $113.9 million (97 cents per share) from $99.0 million (81 cents per share) in the prior year period. That increase got a boost from a pre-tax, non-recurring net benefit of $4.3 million. On an adjusted basis, Donaldson delivered 94 cents per share, topping the 92-cent consensus.
Gross margin came in at 35.2% versus 35.5% in the year-ago quarter, pressured by higher operating costs. The adjusted gross margin showed a similar pattern at 35.4% compared to 35.6% previously. During the quarter, the company returned capital to shareholders with $34.7 million in dividends and $91.9 million in share repurchases.
A Closer Look at the Segments
The Mobile Solutions segment delivered solid growth of 4.5% year over year, benefiting from higher volumes, pricing improvements, and currency tailwinds. Aftermarket sales—the replacement parts that generate recurring revenue—rose an impressive 6.5%, driven by strong original equipment channel demand and market share gains in the independent channel.
Industrial Solutions essentially held steady year over year, with strong pricing and positive currency effects offsetting softer volumes. Within this segment, Aerospace and Defense sales declined 7.1% as Defense sales weakened.
The standout performer was Life Sciences, where sales jumped 13.1% year over year. New equipment sales in Food and Beverage and Disk Drive applications powered the growth, demonstrating the diversification benefits of Donaldson's business model.
Raising the Bar
Management's confidence showed in the revised guidance. Donaldson now expects fiscal 2026 adjusted EPS of $3.95 to $4.11, up from the previous $3.92 to $4.08 range. The new midpoint of $4.03 sits comfortably above the consensus estimate of $4.01.
The sales outlook got an even bigger boost. The company now projects sales growth of 1% to 5% year over year, expanding from the earlier 1% to 3% range. About one percentage point of that growth should come from pricing. Breaking it down by segment, Mobile Solutions is expected to grow flat to up 4%, Industrial Solutions should rise 2% to 6%, and Life Sciences is projected to increase 1% to 5%.
For the full year, management plans to repurchase approximately 2.0% to 3.0% of shares outstanding, continuing its shareholder-friendly capital allocation.
What Management Is Saying
Tod Carpenter, chairman, president, and CEO, emphasized the company's execution amid uncertainty: "In the face of a dynamic macro landscape, and consistent with the value created by our robust portfolio of businesses and product offerings, we gained market share in key businesses and grew replacement part sales through our razor-to-sell-razorblades model. Combined with ongoing expense management, we converted sales growth of 4% into 13% adjusted EPS growth."
That conversion rate—turning 4% top-line growth into 13% earnings growth—speaks to operational leverage and the power of Donaldson's recurring revenue model. Donaldson shares were trading near their 52-week high of $90.94, reaching $89.94 in premarket action.
